Skip to main content

PMV Pharmaceuticals, Inc.

PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001699382

No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in PMV Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
69
+7 vs. Q4 2025
Shares held
37.0M
+1.71M (+4.8%) vs. Q4 2025
Total value
$45.8M
+$1.77M (+4.0%) vs. Q4 2025
New holders
15
16 more added
Sold out
8
20 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 69 institutions
Q1 2021: 81 institutionsQ2 2021: 86 institutionsQ3 2021: 92 institutionsQ4 2021: 105 institutionsQ1 2022: 99 institutionsQ2 2022: 105 institutionsQ3 2022: 120 institutionsQ4 2022: 115 institutionsQ1 2023: 113 institutionsQ2 2023: 106 institutionsQ3 2023: 104 institutionsQ4 2023: 98 institutionsQ1 2024: 99 institutionsQ2 2024: 93 institutionsQ3 2024: 74 institutionsQ4 2024: 70 institutionsQ1 2025: 55 institutionsQ2 2025: 54 institutionsQ3 2025: 64 institutionsQ4 2025: 63 institutionsQ1 2026: 69 institutionsQ2 2026: 64 institutions
Value heldQ1 2026: $45.8M
Q1 2021: $1.31BQ2 2021: $1.44BQ3 2021: $1.31BQ4 2021: $1.10BQ1 2022: $1.15BQ2 2022: $870.9MQ3 2022: $692.3MQ4 2022: $474.5MQ1 2023: $245.7MQ2 2023: $324.0MQ3 2023: $333.0MQ4 2023: $144.0MQ1 2024: $72.7MQ2 2024: $65.6MQ3 2024: $58.2MQ4 2024: $58.8MQ1 2025: $40.7MQ2 2025: $36.8MQ3 2025: $52.5MQ4 2025: $46.8MQ1 2026: $45.8MQ2 2026: $45.9M
Institutions holding PMVP and their total value by quarter
QuarterHoldersValue
Q2 202664$45.9M
Q1 202669$45.8M
Q4 202563$46.8M
Q3 202564$52.5M
Q2 202554$36.8M
Q1 202555$40.7M
Q4 202470$58.8M
Q3 202474$58.2M
Q2 202493$65.6M
Q1 202499$72.7M
Q4 202398$144.0M
Q3 2023104$333.0M
Q2 2023106$324.0M
Q1 2023113$245.7M
Q4 2022115$474.5M
Q3 2022120$692.3M
Q2 2022105$870.9M
Q1 202299$1.15B
Q4 2021105$1.10B
Q3 202192$1.31B
Q2 202186$1.44B
Q1 202181$1.31B

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q4 2025.

Institutions holding PMVP in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Caitong International Asset Management Co., Ltd3$40.00%+3New
Group One Trading, L.P.90$1120.00%+90New
JPMorgan Chase & Co214$2610.00%00.0%Unchanged
UBS Group AG361$4480.00%−737−67.1%Reduced
BNP Paribas Arbitrage, SA539$6680.00%+21+4.1%Added
Royal Bank of Canada904$1.00K0.00%+832+1,155.6%Added
Jones Financial Companies LLLP1,000$1.31K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1,365$1.69K0.00%−2,540−65.0%Reduced
Silver Grove Financial Group, Inc.5,082$6.30K0.01%00.0%Unchanged
Simplex Trading, LLC8,181$10.1K0.00%−19,681−70.6%Reduced
Deerfield Management Company, L.P. (Series C)8,790$10.9K0.00%00.0%Unchanged
GTS Securities LLC10,001$12.4K0.00%−10.0%Reduced
Independent Advisor Alliance12,500$15.5K0.00%00.0%Unchanged
Sand Hill Global Advisors, LLC12,539$15.5K0.00%+12,539New
Ameriprise Financial Inc13,237$16.4K0.00%−51,877−79.7%Reduced
Virtu Financial LLC14,050$17.0K0.00%+1,208+9.4%Added
CI Private Wealth, LLC15,000$18.6K0.00%+15,000New
Gsa Capital Partners LLP15,441$19.0K0.00%+15,441New
Pathstone Holdings, LLC17,487$21.7K0.00%00.0%Unchanged
Citigroup Inc19,296$23.9K0.00%00.0%Unchanged
Public Employees Retirement System of Ohio19,734$24.5K0.00%−7,700−28.1%Reduced
Point72 Asset Management, L.P.20,945$26.0K0.00%−7,799−27.1%Reduced
Vanguard Global Advisers, LLC21,559$26.7K0.00%+21,559New
Boothbay Fund Management, LLC27,126$33.6K0.00%00.0%Unchanged
Squarepoint Ops LLC27,381$34.0K0.00%+879+3.3%Added
Barclays PLC27,536$34.1K0.00%00.0%Unchanged
HSBC Holdings PLC30,891$38.5K0.00%00.0%Unchanged
Connor, Clark & Lunn Investment Management Ltd.32,460$40.3K0.00%+32,460New
Algert Global LLC41,590$51.6K0.00%−20,430−32.9%Reduced
Citadel Advisors LLC45,048$55.9K0.00%−73,545−62.0%Reduced
Accurate Wealth Management, LLC50,000$66.5K0.01%+50,000New
Quadrature Capital Ltd61,174$75.9K0.00%+42,746+232.0%Added
Seven Fleet Capital Management LP63,498$78.7K0.02%00.0%Unchanged
Rangeley Capital, LLC66,846$82.9K0.09%+21,346+46.9%Added
The PNC Financial Services Group, Inc.68,292$84.7K0.00%−4,919−6.7%Reduced
Velan Capital Investment Management LP73,000$90.5K0.06%+38,000+108.6%Added
Ikarian Capital, LLC89,136$110.5K0.02%00.0%Unchanged
Goldman Sachs Group Inc114,864$142.4K0.00%−12,177−9.6%Reduced
Northern Trust Corp115,422$143.1K0.00%−266,666−69.8%Reduced
BIT Capital GmbH123,555$153.2K0.01%+123,555New
Jane Street Group, LLC124,014$153.8K0.00%−374,627−75.1%Reduced
Evoke Wealth, LLC133,122$165.1K0.00%00.0%Unchanged
RBF Capital, LLC162,200$201.1K0.01%00.0%Unchanged
Jacobs Levy Equity Management, Inc179,873$223.0K0.00%−344,477−65.7%Reduced
Verdad Advisers, LP180,161$223.4K0.25%+180,161New
State Street Corp183,178$227.1K0.00%00.0%Unchanged
ADAR1 Capital Management, LLC231,008$286.4K0.02%+130,000+128.7%Added
Bank of America Corp240,531$298.3K0.00%+393+0.2%Added
Vanguard Fiduciary Trust Co298,126$369.7K0.00%+298,126New
Walleye Capital LLC335,694$416.3K0.00%00.0%Unchanged
Assenagon Asset Management S.A.360,786$447.4K0.00%+220,318+156.8%Added
Bridgeway Capital Management, LLC428,853$531.8K0.01%00.0%Unchanged
Marshall Wace, LLP434,093$538.3K0.00%−30,993−6.7%Reduced
Aldebaran Capital, LLC473,362$587.0K0.45%−4,626−1.0%Reduced
Geode Capital Management, LLC495,922$615.5K0.00%+49,782+11.2%Added
Longaeva Partners L.P.552,027$684.5K0.03%+552,027New
Stonepine Capital Management, LLC708,102$878.0K0.77%−442,657−38.5%Reduced
Morgan Stanley864,311$1.07M0.00%+765,436+774.1%Added
BlackRock, Inc.874,374$1.08M0.00%−220,509−20.1%Reduced
Adage Capital Partners GP, L.L.C.1,860,000$2.31M0.00%+1,860,000New
Two Sigma Investments, LP1,884,530$2.34M0.00%+1,178,469+166.9%Added
Vanguard Capital Management LLC1,974,906$2.45M0.00%+1,974,906New
Acadian Asset Management LLC2,215,894$2.75M0.00%+200,124+9.9%Added
Eversept Partners, LP2,348,360$2.91M0.19%+2,348,360New
Euclidean Capital LLC2,627,643$3.26M0.83%00.0%Unchanged
ArrowMark Colorado Holdings LLC2,872,764$3.56M0.09%−217,329−7.0%Reduced
Sio Capital Management, LLC3,076,580$3.81M0.55%+440,032+16.7%Added
Tang Capital Management LLC4,245,085$5.26M0.27%−694,915−14.1%Reduced
BML Capital Management, LLC5,320,000$6.60M4.24%+28,000+0.5%Added
OrbiMed Advisors LLC0$00.00%−4,975,291−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−874,100−100.0%Sold out
XTX Topco Ltd0$00.00%−104,485−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−78,784−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−23,369−100.0%Sold out
Bailard, Inc.0$00.00%−17,069−100.0%Sold out
Nine Masts Capital Ltd0$00.00%−16,607−100.0%Sold out
Torren Management, LLC0$00.00%−4,716−100.0%Sold out
Vanguard Group Inc––––Not filed